Search Results - "DEDE, İsa"

The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer by Karaağaç, Mustafa, Geredeli, Çağlayan, Yıldırım, Mahmut, Altınok, Tamer, Dede, İsa, İnal, Ali, Zamani, Ayşe, Kaya, Buğra, Demirkazık, Ahmet, Artaç, Mehmet

“…Background: Studies on single nucleotide polymorphisms (SNPs) in non-small cell lung cancer (NSCLC) suggest that DNA repair capacity may have prognostic…”
Get full text

Survival Analysis in Colon Cancer Patients by ULGEN, Ayse, ÇETİN, Şirin, DEDE, İsa

“…Introduction: The aim of this study is to investigate the degree of risk and significance of prognostic and demographic factors affecting the survival of…”
Get full text

Evaluation of Death Risks of Lung Cancer Patients with Frailty Models by PASİN, Özge, ÇETİN, Şirin, DEDE, İsa

“…OBJECTIVE:The aim of this study is to investigate the prognostic factors of lung cancer by evaluating the most appropriate survival model with a selection…”
Get full text

Prognostic value of the neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 in estimating survival in patients with metastatic pancreatic cancer by Cetin, Sirin, Dede, Isa

“…Background: The predictive value of different prognostic biomarkers has been studied in various cancer types. Aims and Objectives: The purpose of this study…”
Get full text

PD-L1 Expression in Colorectal Adenocarcinoma Is Associated With the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition by Secinti, Ilke Evrim, Ozgur, Tumay, Dede, Isa

“…Abstract Objectives Colorectal carcinomas are the third-most common tumors in the world, and colorectal cancer ranks second in cancer-related deaths. Our aim…”
Get full text

Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas? by Secinti, Ilke Evrim, Ozgur, Tumay, Gursoy, Didar, Dede, Isa

“…The aim of this study was to investigate the relationship between tumor budding (TB) and clinicopathologic prognostic criteria in colorectal adenocarcinomas…”
Get full text

On Fair Performance Comparison between Random Survival Forest and Cox Regression: An Example of Colorectal Cancer Study by Cetin, Sirin, Ulgen, Ayse, Dede, Isa, Li, Wentian

“…Random Forest (RF), a mostly model-free and robust machine learning method, has been successfully applied to right-censored survival data, under the name of…”
Get full text

Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy by Karacin, Cengiz, Oksuzoglu, Berna, Demirci, Ayşe, Keskinkılıç, Merve, Baytemür, Naziyet Köse, Yılmaz, Funda, Selvi, Oğuzhan, Erdem, Dilek, Avşar, Esin, Paksoy, Nail, Demir, Necla, Göksu, Sema Sezgin, Türker, Sema, Bayram, Ertuğrul, Çelebi, Abdüssamet, Yılmaz, Hatice, Kuzu, Ömer Faruk, Kahraman, Seda, Gökmen, İvo, Sakin, Abdullah, Alkan, Ali, Nayır, Erdinç, Uğraklı, Muzaffer, Acar, Ömer, Ertürk, İsmail, Demir, Hacer, Aslan, Ferit, Sönmez, Özlem, Korkmaz, Taner, Celayir, Özde Melisa, Karadağ, İbrahim, Kayıkçıoğlu, Erkan, Şakalar, Teoman, Öktem, İlker Nihat, Eren, Tülay, Urul, Enes, Mocan, Eda Eylemer, Kalkan, Ziya, Yıldırım, Nilgün, Ergün, Yakup, Akagündüz, Baran, Karakaya, Serdar, Kut, Engin, Teker, Fatih, Demirel, Burçin Çakan, Karaboyun, Kubilay, Almuradova, Elvina, Ünal, Olçun Ümit, Oyman, Abdilkerim, Işık, Deniz, Okutur, Kerem, Öztosun, Buğra, Gülbağcı, Burcu Belen, Kalender, Mehmet Emin, Şahin, Elif, Seyyar, Mustafa, Özdemir, Özlem, Selçukbiricik, Fatih, Kanıtez, Metin, Dede, İsa, Gümüş, Mahmut, Gökmen, Erhan, Yaren, Arzu, Menekşe, Serkan, Ebinç, Senar, Aksoy, Sercan, İmamoğlu, Gökşen İnanç, Altınbaş, Mustafa, Çetin, Bülent, Uluç, Başak Oyan, Er, Özlem, Karadurmuş, Nuri, Erdoğan, Atike Pınar, Artaç, Mehmet, Tanrıverdi, Özgür, Çiçin, İrfan, Şendur, Mehmet Ali Nahit, Oktay, Esin, Bayoğlu, İbrahim Vedat, Paydaş, Semra, Aydıner, Adnan, Salim, Derya Kıvrak, Geredeli, Çağlayan, Yavuzşen, Tuğba, Doğan, Mutlu, Hacıbekiroğlu, İlhan

“…There is no standard treatment recommended at category 1 level in international guidelines for subsequent therapy after cyclin-dependent kinase 4/6 inhibitor…”
Get full text

Correction: Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy by Karacin, Cengiz, Oksuzoglu, Berna, Demirci, Ayşe, Keskinkılıç, Merve, Baytemür, Naziyet Köse, Yılmaz, Funda, Selvi, Oğuzhan, Erdem, Dilek, Avşar, Esin, Paksoy, Nail, Demir, Necla, Göksu, Sema Sezgin, Türker, Sema, Bayram, Ertuğrul, Çelebi, Abdüssamet, Yılmaz, Hatice, Kuzu, Ömer Faruk, Kahraman, Seda, Gökmen, İvo, Sakin, Abdullah, Alkan, Ali, Nayır, Erdinç, Uğraklı, Muzafer, Acar, Ömer, Ertürk, İsmail, Demir, Hacer, Aslan, Ferit, Sönmez, Özlem, Korkmaz, Taner, Celayir, Özde Melisa, Karadağ, İbrahim, Kayıkçıoğlu, Erkan, Şakalar, Teoman, Öktem, İlker Nihat, Eren, Tülay, Erul, Enes, Mocan, Eda Eylemer, Kalkan, Ziya, Yıldırım, Nilgün, Ergün, Yakup, Akagündüz, Baran, Karakaya, Serdar, Kut, Engin, Teker, Fatih, Demirel, Burçin Çakan, Karaboyun, Kubilay, Almuradova, Elvina, Ünal, Olçun Ümit, Oyman, Abdilkerim, Işık, Deniz, Okutur, Kerem, Öztosun, Buğra, Gülbağcı, Burcu Belen, Kalender, Mehmet Emin, Şahin, Elif, Seyyar, Mustafa, Özdemir, Özlem, Selçukbiricik, Fatih, Kanıtez, Metin, Dede, İsa, Gümüş, Mahmut, Gökmen, Erhan, Yaren, Arzu, Menekşe, Serkan, Ebinç, Senar, Aksoy, Sercan, İmamoğlu, Gökşen İnanç, Altınbaş, Mustafa, Çetin, Bülent, Uluç, Başak Oyan, Er, Özlem, Karadurmuş, Nuri, Erdoğan, Atike Pınar, Artaç, Mehmet, Tanrıverdi, Özgür, Çiçin, İrfan, Şendur, Mehmet Ali Nahit, Oktay, Esin, Bayoğlu, İbrahim Vedat, Paydaş, Semra, Aydıner, Adnan, Salim, Derya Kıvrak, Geredeli, Çağlayan, Yavuzşen, Tuğba, Doğan, Mutlu, Hacıbekiroğlu, İlhan

Get full text

Efficacy of Perioperative FLOT Therapy in Locally Advanced Gastric Cancer and the Associated Prognostic Factors by YILDIRAN KESKİN, Gül Sema, ERTÜRK, İsmail, AYKAN, Musa Barış, ACAR, Ramazan, TOPAL, Alper, DUMLUDAĞ, Ayşegül, KÖSEOĞLU, Çağlar, KUZU, Ömer Faruk, DURMAZ, Pelin, DEDE, İsa, KÖSE, Ahmet Fatih, KARADURMUŞ, Nuri

Get full text

Using Interferon Alfa Before Tyrosine Kinase Inhibitors May Increase Survival in Patients With Metastatic Renal Cell Carcinoma: A Turkish Oncology Group (TOG) Study by Artaç, Mehmet, Çoşkun, Hasan Şenol, Korkmaz, Levent, Koçer, Murat, Turhal, Nazım Serdar, Engin, Hüseyin, Dede, İsa, Paydaş, Semra, Öksüzoğlu, Berna, Bozcuk, Hakan, Demirkazık, Ahmet

“…Survival outcomes of interferon-alfa and tyrosine kinase inhibitors for 104 cases of metastatic renal cell carcinoma were included in this study. First-line…”
Get full text

Using interferon-alpha before tyrosine kinase inhibitors may increase survival in metastatic renal cell carcinoma patients: a Turkish Oncology Group (TOG) study by Artaç, Mehmet, Çoşkun, Hasan Şenol, Korkmaz, Levent, Koçer, Murat, Turhal, Nazım Serdar, Engin, Hüseyin, Dede, İsa, Paydaş, Semra, Öksüzoğlu, Berna, Bozcuk, Hakan, Demirkazık, Ahmet

“…Abstract Background We aimed to investigate outcomes of interferon-alpha and sequencing tyrosine kinase inhibitors in metastatic renal cell carcinoma. Patients…”
Get full text

Mide kanseri ve ABO kan grubu ilişkisi: çok merkezli, gözlemsel, vaka-kontrol çalışması by YAŞAR, Hatime Arzu, UTKAN, Güngör, YILDIRIM, Nuriye, ÖKSÜZOĞLU, Berna, DEDE, İsa, ÜRÜN, Yüksel, AKBULUT, Hakan

“…Giriş ve Amaç: Bu çalışmanın amacı, kan grupları ile mide kanseri riski arasındaki ilişkiyi araştırmaktır. Gereç ve Yöntem: Çok merkezli, gözlemsel,…”
Get full text

Independent prognostic value of inflammation in metastatic pancreatic cancer by Oksuzoglu, Berna, Esin, Ece, Koksoy, Elif Berna, Demirci, Nebi Serkan, Sendur, Mehmet Ali Nahit, Dede, Isa, Sezer, Ahmet, Karcı, Ebru, Yildirim, Nuriye, Yalcin, Bulent, Utkan, Gungor, Urun, Yuksel

“…Abstract only…”
Get full text

Should we report Breslow density, a new concept in cutaneous melanoma? by Secinti, I E, Gursoy, D, Erturk, T, Dede, I, Ozgur, T, Dogan, E

“…Breslow density is a newly defined biomarker, independent of Breslow thickness. We aimed to investigate the relationship of Breslow density with other…”
Get more information

Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis by Ergun, Yakup, Ozdemir, Nuriye Yildirim, Guner, Ebru Karci, Esin, Ece, Sendur, Mehmet Ali, Koksoy, Elif Berna, Demirci, Nebi Serkan, Eren, Tulay, Dede, Isa, Sezer, Ahmet, Engin, Huseyin, Oksuzoglu, Berna, Yalcin, Bulent, Utkan, Gungor, Zengin, Nurullah, Urun, Yuksel

“…Gemcitabine is among the standard first-line agents for the treatment of metastatic pancreatic cancer. However, as the median survival with gemcitabine…”
Get more information

Serum CEA and CA 15-3 levels according to breast cancer subtypes by Dede, Isa, Utkan, Gungor, Akbulut, Hakan, Urun, Yuksel, Mizrak, Dilsa, Icli, Fikri

“…Abstract only e11511 Background: Carcinoembryonic antigen (CEA) and carbohydrate antigen (CA) 15-3 are frequently elevated in patients with metastatic breast…”
Get full text

Relation of metastatic stage at the diagnosis of non-small cell lung cancer (NSCLC) to XRCC1 and TP53 single nucleotide polymorphisms (SNPs) by Artac, Mehmet, Geredeli, Caglayan, Yildirim, Selman, Dede, Isa, Inal, Ali, Guler, Tunc, Boruban, Melih Cem, Zamani, Ayse Gul, Demirkazik, Ahmet, Bozcuk, Hakan Sat

“…Abstract only…”
Get full text

Prognostic value of ERCC1, ERCC2, XRCC1, and TP53 single nucleotide polymorphisms in patients with early-stage non-small cell lung cancer by Geredeli, Caglayan, Artac, Mehmet, Yildirim, Selman, Inal, Ali, Dede, Isa, Guler, Tunc, Boruban, Melih Cem, Koral, Lokman, Karaagac, Mustafa, Zamani, Ayse Gul, Altinok, Tamer, Aribas, Olgun, Bozcuk, Hakan, Demirkazik, Ahmet

“…Identification of biomarkers used for the prognostic evaluation of non-small cell lung cancer (NSCLC) patients is important. The aim of this study was to…”
Get full text

Sunitinib for patients with metastatic non-clear cell renal cell carcinoma: a Multicenter Retrospective Turkish Oncology Group trial by Yildiz, Ibrahim, Ekenel, Meltem, Akman, Tulay, Kocar, Muharrem, Uysal, Mükremin, Kanitez, Metin, Varol, Umut, Bayoglu, Ibrahim Vedat, Tural, Deniz, Kaplan, Mehmet Ali, Avci, Nilufer, Sürmeli, Zeki, Dede, İsa, Ulaş, Arife, Yazici, Ozan, Basaran, Mert

“…This study aimed to assess the clinical efficacy and toxicity of sunitinib, a targeted-agent, for non-clear cell renal cell carcinoma. Sixty-three patients…”
Get full text